Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All...
  • Videos
  • Collections
    • Recently published
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Transfers
  • Current issue
  • Past issues
  • By specialty
  • Contact
  • Recently published
  • Technical Advances
  • Clinical Medicine
  • Editorials
  • Top read articles
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI Insight
  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement

Clinical MedicineIn-Press PreviewImmunologyInfectious disease Free access | 10.1172/jci.insight.130540

BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults

Srabanti Rakshit, Asma Ahmed, Vasista Adiga, Bharath K. Sundararaj, Pravat Nalini Sahoo, John Kenneth, George D'Souza, Wesley Bonam, Christina Johnson, Kees L.M.C. Franken, Tom H.M. Ottenhoff, Greg Finak, Raphael Gottardo, Kenneth D. Stuart, Stephen C. De Rosa, M. Juliana McElrath, and Annapurna Vyakarnam

Find articles by Rakshit, S. in: JCI | PubMed | Google Scholar

Find articles by Ahmed, A. in: JCI | PubMed | Google Scholar

Find articles by Adiga, V. in: JCI | PubMed | Google Scholar |

Find articles by Sundararaj, B. in: JCI | PubMed | Google Scholar |

Find articles by Sahoo, P. in: JCI | PubMed | Google Scholar

Find articles by Kenneth, J. in: JCI | PubMed | Google Scholar

Find articles by D'Souza, G. in: JCI | PubMed | Google Scholar

Find articles by Bonam, W. in: JCI | PubMed | Google Scholar

Find articles by Johnson, C. in: JCI | PubMed | Google Scholar

Find articles by Franken, K. in: JCI | PubMed | Google Scholar

Find articles by Ottenhoff, T. in: JCI | PubMed | Google Scholar |

Find articles by Finak, G. in: JCI | PubMed | Google Scholar |

Find articles by Gottardo, R. in: JCI | PubMed | Google Scholar |

Find articles by Stuart, K. in: JCI | PubMed | Google Scholar

Find articles by De Rosa, S. in: JCI | PubMed | Google Scholar |

Find articles by McElrath, M. in: JCI | PubMed | Google Scholar

Find articles by Vyakarnam, A. in: JCI | PubMed | Google Scholar

First published November 19, 2019 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.130540.
Copyright © 2019, American Society for Clinical Investigation
First published November 19, 2019 - Version history
Abstract

Background: Bacille Calmette-Guérin (BCG) vaccine is protective in children but its efficacy wanes with age. Consequently, determining if BCG revaccination augments anti-TB immunity in young adults in TB endemic regions is vital.

Methods: 200 healthy adults, BCG vaccinated at birth were tested for their IGRA status. Of these, 28 IGRA+ and 30 IGRA- were BCG revaccinated and 24 IGRA+ and 23 IGRA- subjects served as unvaccinated controls. T and innate cell responses to mycobacterial antigens were analyzed by 14-colour flow cytometry over 34 weeks.

Results: IFN-γ and/or IL-2 Ag85A and BCG-specific CD4+ and CD8+ T-cell responses were boosted by revacciantion at 4 and 34 weeks respectively and were >2-fold higher in IGRA+ compared to IGRA- vaccinees. Polyfunctional Ag85A, BCG and Mtb latency Ag (LTAg)-specific CD4+ T-cells expressing up to 8 cytokines were also significantly enhanced in both IGRA+ and IGRA- vaccinees relative to unvaccinated controls, most markedly in IGRA+ vaccinees. A focussed analysis of Th17 responses revealed expansion of Ag85A, BCG and LTAg-specific total IL-17A+IL-17F+IL-22+ and IL-10+ CD4+ T-cell effectors in both IGRA+ and IGRA- subjects. Also, innate IFN-γ+ NK/γδ/NKT responses were higher in both IGRA+ and IGRA- vaccinees compared to controls. This is the first evidence that BCG revaccination significantly boosts anti-mycobacterial Th1/Th17 responses in IGRA+ and IGRA- subjects.

Summary: These data show that BCG revaccination is immunogenic in IGRA- and IGRA+ subjects implying that Mtb pre-infection in IGRA+ subjects does not impact immunogenicity. This has implications for public health and vaccine development strategies.

Funding: This work was funded principally by DBT-NIH (BT/MB/Indo-US/HIPC/2013).

Graphical Abstract
graphical abstract
Supplemental material

View

View Supplemental File 1

Version history
  • Version 1 (November 19, 2019): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI Insight

Go to:

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement
Follow JCI Insight:
Copyright © 2019 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts